Analyst Ratings for NeuroSense Therapeutics Ltd. (NRSN)
NRSN Rating Summary
NRSN Price Target Summary
- Highest: $9.00 (Noble Capital)
- Lowest: $3.00 (Roth/MKM)
- Average: $6.67
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$6.67 (+1860.8%)
* Over Last 12-Mos
Rating Score: 8.3 / 10
Percentile Rank: 85%
Avg. $ Target:
$6.67 (+1860.8%)
* Over Last 12-Mos
Rating Score: 8.3 / 10
Percentile Rank: 85%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/3/2026 | H.C. Wainwright | Lander Egana Gorrono | New Coverage | Buy (N/A) |
8.00 (N/A) |
0.41 (0.34) |
-17.07% | Details |
| 3/10/2026 | Roth/MKM | Boobalan Pachaiyappan | New Coverage | Buy (N/A) |
3.00 (N/A) |
0.87 (0.34) |
-60.92% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
